Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Anti-Glutamic Acid Antibody (Anti-Glu)
Glutamate
- Product No.AES122Ge
- Organism SpeciesPan-species (General) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodIndirect ELISA
- Assay Length2h, 30min
- Detection Range3.12-200ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.21ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 644
For more details, please contact local distributors! US$ 920 US$ 4140 US$ 7820 US$ 64400
Specificity
This assay has high sensitivity and excellent specificity for detection of Anti-Glutamic Acid Antibody (Anti-Glu).
No significant cross-reactivity or interference between Anti-Glutamic Acid Antibody (Anti-Glu) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of Anti-Glutamic Acid Antibody (Anti-Glu) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Glutamic Acid Antibody (Anti-Glu) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 82-101 | 97 |
EDTA plasma(n=5) | 93-101 | 97 |
heparin plasma(n=5) | 86-96 | 92 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Glutamic Acid Antibody (Anti-Glu) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Glutamic Acid Antibody (Anti-Glu) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Glutamic Acid Antibody (Anti-Glu) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 78-90% | 88-103% | 99-105% | 89-96% |
EDTA plasma(n=5) | 79-101% | 80-101% | 99-105% | 98-105% |
heparin plasma(n=5) | 95-104% | 86-103% | 94-101% | 93-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Neurobiology of Disease | Critical role for Annexin A7 in secondary brain injury mediated by its phosphorylation after experimental intracerebral hemorrhage in rats pubmed:29196215 |
Nutrients | High-dose Glycerol Monolaurate Up-Regulated Beneficial Indigenous Microbiota without Inducing Metabolic Dysfunction and Systemic Inflammation: New Insights … |
Journal of neural transmission (Vienna, Austria : 1996) | Neurotransmitter system aberrations in patients with drug addiction Pubmed: 32804296 |
Mol Med Rep | ¦Ê?opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca2+/CaMKII/CREB signaling pathway and improves synaptic plasticity in ¡ 34036389 |
Neuroscience | Ah-type baroreceptor neurons expressing estrogen dependent mGluR7 mediate descending inhibition of cardiac nociception Pubmed:35436518 |
J Clin Med | Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients … Pubmed:35566558 |
J Inflamm Res | The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca2+/CaMKII/CREB Pathway in Rats Pubmed:35645576 |
Catalog No. | Related products for research use of Pan-species (General) Organism species | Applications (RESEARCH USE ONLY!) |
CPS122Ge21 | OVA Conjugated Glutamic Acid (Glu) | Immunogen; SDS-PAGE; WB. |
CPS122Ge11 | BSA Conjugated Glutamic Acid (Glu) | Immunogen; SDS-PAGE; WB. |
PAS122Ge01 | Polyclonal Antibody to Glutamic Acid (Glu) | ELISA, CLIA. / IHC-Fr, ICC, IP (predicted). |
CES122Ge | ELISA Kit for Glutamic Acid (Glu) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AES122Ge | ELISA Kit for Anti-Glutamic Acid Antibody (Anti-Glu) | Enzyme-linked immunosorbent assay for Antibody Detection. |
LMS122Ge | Multiplex Assay Kit for Glutamic Acid (Glu) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSS122Ge11 | ELISA Kit DIY Materials for Glutamic Acid (Glu) | Main materials for "Do It (ELISA Kit) Yourself". |